ZETA OPTIX LTD

Company number 14573539 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

ZETA OPTIX LTD - Analysis Report

Company Number: 14573539

Analysis Date: 2025-07-29 18:17 UTC

Financial Health Assessment Report for ZETA OPTIX LTD
Assessment Date: Based on latest financials as of 31 January 2024


1. Financial Health Score: B

Explanation:
ZETA OPTIX LTD demonstrates a solid financial foundation for a newly incorporated micro-entity. The company shows a healthy net asset base and strong working capital relative to its scale, which supports ongoing operational stability. However, as a very young business with limited trading history and minimal fixed assets, it does not yet exhibit the full financial maturity or diversification typical of higher-rated firms. The financial "pulse" is steady but early-stage.


2. Key Vital Signs

Metric Value Interpretation
Fixed Assets £1,508 Minimal investment in long-term assets; typical for a startup or service-focused micro business.
Current Assets £46,592 Healthy level of liquid assets, indicating good cash and receivables position.
Current Liabilities £15,389 Manageable short-term obligations; less than half of current assets, positive liquidity sign.
Net Current Assets (Working Capital) £31,203 Strong positive working capital, showing good short-term financial health and operational liquidity ("healthy blood flow").
Net Assets / Shareholders Funds £33,711 Positive net worth; company equity exceeds liabilities, indicating a sound financial foundation.
Number of Employees 1 Micro-entity status with minimal staffing, consistent with early-stage business.
Account Category Micro Simplified reporting regime, suitable for small scale operations.
Control Single shareholder/director with 75-100% ownership and voting rights, ensuring clear governance.

Additional observations:

  • No overdue filings, indicating good compliance health.
  • No indication of debt or financial distress symptoms.
  • The "symptoms" of financial distress such as negative working capital, large creditor balances, or net liability position are absent.

3. Diagnosis

ZETA OPTIX LTD is in a healthy financial state for a micro-entity in its first year of trading. The company has successfully maintained positive net current assets, which means it has more short-term assets than liabilities to cover immediate obligations — akin to having a strong pulse and stable blood pressure in medical terms. The net asset position indicates that the business is not burdened by debt and has a positive equity buffer.

The small fixed asset base is expected given the company's young age and sector (other human health activities), which may rely more on intellectual capital or service delivery than heavy equipment. The single director and shareholder structure simplifies decision-making but also concentrates risk in one individual.

No overt symptoms of financial distress such as overdue filings, negative net assets, or operational losses reported (within the limitations of micro-entity accounts) have been noted. The company appears well-positioned for stable growth but is still in the early stages of its financial lifecycle.


4. Recommendations

To maintain and improve financial wellness, the following steps are advised:

  1. Maintain Strong Liquidity: Continue monitoring working capital closely to ensure operational expenses and supplier payments remain covered without strain. Healthy cash flow is vital, especially in early years.

  2. Build Asset Base Prudently: Plan gradual investment in fixed assets or intangible assets (e.g., technology, intellectual property) to support growth and operational efficiency, avoiding overextension.

  3. Diversify Funding Sources: While current equity funding is sufficient, consider developing relationships with financial institutions or investors to prepare for scaling needs.

  4. Enhance Financial Reporting: As the company grows, consider moving beyond micro-entity accounts to fuller financial disclosures for better insight and stakeholder confidence.

  5. Risk and Governance: With a single controlling director/shareholder, it is important to ensure robust internal controls and possibly seek advisory input to mitigate concentration risk.

  6. Plan for Growth: Strategically develop business plans and financial forecasts to guide expansion, including marketing, hiring, and operational scaling.


Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 29 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.